BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baburamani AA, Patkee PA, Arichi T, Rutherford MA. New approaches to studying early brain development in Down syndrome. Dev Med Child Neurol 2019;61:867-79. [PMID: 31102269 DOI: 10.1111/dmcn.14260] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Cañete-massé C, Carbó-carreté M, Peró-cebollero M, Cui S, Yan C, Guàrdia-olmos J. Altered spontaneous brain activity in Down syndrome and its relation with cognitive outcome. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-19627-1] [Reference Citation Analysis]
2 Manfredi-Lozano M, Leysen V, Adamo M, Paiva I, Rovera R, Pignat JM, Timzoura FE, Candlish M, Eddarkaoui S, Malone SA, Silva MSB, Trova S, Imbernon M, Decoster L, Cotellessa L, Tena-Sempere M, Claret M, Paoloni-Giacobino A, Plassard D, Paccou E, Vionnet N, Acierno J, Maceski AM, Lutti A, Pfrieger F, Rasika S, Santoni F, Boehm U, Ciofi P, Buée L, Haddjeri N, Boutillier AL, Kuhle J, Messina A, Draganski B, Giacobini P, Pitteloud N, Prevot V. GnRH replacement rescues cognition in Down syndrome. Science 2022;377:eabq4515. [PMID: 36048943 DOI: 10.1126/science.abq4515] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Risgaard KA, Sorci IA, Mohan S, Bhattacharyya A. Meta-Analysis of Down Syndrome Cortical Development Reveals Underdeveloped State of the Science. Front Cell Neurosci 2022;16:915272. [DOI: 10.3389/fncel.2022.915272] [Reference Citation Analysis]
4 Hasina Z, Wang N, Wang CC. Developmental Neuropathology and Neurodegeneration of Down Syndrome: Current Knowledge in Humans. Front Cell Dev Biol 2022;10:877711. [DOI: 10.3389/fcell.2022.877711] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Stagni F, Bartesaghi R. The Challenging Pathway of Treatment for Neurogenesis Impairment in Down Syndrome: Achievements and Perspectives. Front Cell Neurosci 2022;16:903729. [DOI: 10.3389/fncel.2022.903729] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Henneman P, Mul AN, Li Yim AY, Krzyzewska IM, Alders M, Adelia A, Mizee MR, Mannens MM. Prenatal NeuN+ neurons of Down syndrome display aberrant integrative DNA methylation and gene expression profiles. Epigenomics 2022. [PMID: 35232286 DOI: 10.2217/epi-2021-0523] [Reference Citation Analysis]
7 Onnivello S, Pulina F, Locatelli C, Marcolin C, Ramacieri G, Antonaros F, Vione B, Caracausi M, Lanfranchi S. Cognitive profiles in children and adolescents with Down syndrome. Sci Rep 2022;12:1936. [PMID: 35121796 DOI: 10.1038/s41598-022-05825-4] [Reference Citation Analysis]
8 Nicholson R, Osborne D, Fairhead L, Beed L, Hill CM, Lee H. Segmentation of the foveal and parafoveal retinal architecture using handheld spectral-domain optical coherence tomography in children with Down syndrome. Eye (Lond) 2022. [PMID: 35001092 DOI: 10.1038/s41433-021-01883-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ponroy Bally B, Murai KK. Astrocytes in Down Syndrome Across the Lifespan. Front Cell Neurosci 2021;15:702685. [PMID: 34483840 DOI: 10.3389/fncel.2021.702685] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
10 Mollo N, Esposito M, Aurilia M, Scognamiglio R, Accarino R, Bonfiglio F, Cicatiello R, Charalambous M, Procaccini C, Micillo T, Genesio R, Calì G, Secondo A, Paladino S, Matarese G, De Vita G, Conti A, Nitsch L, Izzo A. Human Trisomic iPSCs from Down Syndrome Fibroblasts Manifest Mitochondrial Alterations Early during Neuronal Differentiation. Biology (Basel) 2021;10:609. [PMID: 34209429 DOI: 10.3390/biology10070609] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
11 Perenc L, Guzik A, Podgórska-Bednarz J, Drużbicki M. Microsomic and macrosomic body structure in children and adolescents affected by syndromes or diseases associated with neurodysfunction. Sci Rep 2021;11:6349. [PMID: 33737592 DOI: 10.1038/s41598-021-85587-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Reiche L, Göttle P, Lane L, Duek P, Park M, Azim K, Schütte J, Manousi A, Schira-Heinen J, Küry P. C21orf91 Regulates Oligodendroglial Precursor Cell Fate-A Switch in the Glial Lineage? Front Cell Neurosci 2021;15:653075. [PMID: 33796011 DOI: 10.3389/fncel.2021.653075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
13 Patkee PA, Baburamani AA, Long KR, Dimitrova R, Ciarrusta J, Allsop J, Hughes E, Kangas J, McAlonan GM, Rutherford MA, De Vita E. Neurometabolite mapping highlights elevated myo-inositol profiles within the developing brain in down syndrome. Neurobiol Dis 2021;153:105316. [PMID: 33711492 DOI: 10.1016/j.nbd.2021.105316] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Bayona-Bafaluy MP, Garrido-Pérez N, Meade P, Iglesias E, Jiménez-Salvador I, Montoya J, Martínez-Cué C, Ruiz-Pesini E. Down syndrome is an oxidative phosphorylation disorder. Redox Biol 2021;41:101871. [PMID: 33540295 DOI: 10.1016/j.redox.2021.101871] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
15 Del Hoyo Soriano L, Rosser T, Hamilton D, Wood T, Abbeduto L, Sherman S. Gestational age is related to symptoms of attention-deficit/hyperactivity disorder in late-preterm to full-term children and adolescents with down syndrome. Sci Rep 2020;10:20345. [PMID: 33230240 DOI: 10.1038/s41598-020-77392-5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Vicente A, Bravo-González LA, López-Romero A, Muñoz CS, Sánchez-Meca J. Craniofacial morphology in down syndrome: a systematic review and meta-analysis. Sci Rep 2020;10:19895. [PMID: 33199843 DOI: 10.1038/s41598-020-76984-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
17 Yun HJ, Perez JDR, Sosa P, Valdés JA, Madan N, Kitano R, Akiyama S, Skotko BG, Feldman HA, Bianchi DW, Grant PE, Tarui T, Im K. Regional Alterations in Cortical Sulcal Depth in Living Fetuses with Down Syndrome. Cereb Cortex 2021;31:757-67. [PMID: 32940649 DOI: 10.1093/cercor/bhaa255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
18 Baburamani AA, Vontell RT, Uus A, Pietsch M, Patkee PA, Wyatt-Ashmead J, Chin-Smith EC, Supramaniam VG, Donald Tournier J, Deprez M, Rutherford MA. Assessment of radial glia in the frontal lobe of fetuses with Down syndrome. Acta Neuropathol Commun 2020;8:141. [PMID: 32819430 DOI: 10.1186/s40478-020-01015-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
19 Thomas MSC, Ojinaga Alfageme O, D'Souza H, Patkee PA, Rutherford MA, Mok KY, Hardy J, Karmiloff-Smith A; LonDownS Consortium. A multi-level developmental approach to exploring individual differences in Down syndrome: genes, brain, behaviour, and environment. Res Dev Disabil 2020;104:103638. [PMID: 32653761 DOI: 10.1016/j.ridd.2020.103638] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
20 Carbó-Carreté M, Cañete-Massé C, Peró-Cebollero M, Guàrdia-Olmos J. Using fMRI to Assess Brain Activity in People With Down Syndrome: A Systematic Review. Front Hum Neurosci 2020;14:147. [PMID: 32395104 DOI: 10.3389/fnhum.2020.00147] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
21 Reiche L, Küry P, Göttle P. Aberrant Oligodendrogenesis in Down Syndrome: Shift in Gliogenesis? Cells 2019;8:E1591. [PMID: 31817891 DOI: 10.3390/cells8121591] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
22 [DOI: 10.1101/683656] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]